| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ba782d3b1fd168eab19dd7b0875942aa |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4412
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4412
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44 |
| filingDate |
2000-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2003-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5dde5ec1e8144a8eae0ea5656b0df486
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4a554999682f4b137cb6ebae8e145f81 |
| publicationDate |
2003-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-6531493-B1 |
| titleOfInvention |
3-cyclopropylmethoxy-4-difluoromethoxy-N-(3,5-dichloropyrid-4-yl)benzamide in the treatment of multiple sclerosis |
| abstract |
The invention relates to the novel use of 3-cyclopropylmethoxy-4-difluoromethoxy-N-(3,5-dichloropyrid-4-yl)benzamide, a pharmacologically tolerable salt thereof or its N-oxide in the treatment of multiple sclerosis. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007270441-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8663694-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006269600-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8536206-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8604064-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8431154-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9468598-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008193544-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8618142-B2 |
| priorityDate |
1999-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |